US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ODDITY Tech Ltd.

14.14

-0.2600-1.81%

Post-market: 14.10-0.0400-0.28%16:12 EDT

Volume:655.27K

Turnover:9.49M

Market Cap:652.20M

PE:17.90

High:15.18

Open:14.49

Low:14.07

Close:14.40

52wk High:64.23

52wk Low:9.25

Shares:46.12M

Float Shares:28.59M

Volume Ratio:0.81

T/O Rate:2.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.7900

EPS(LYR):1.80

ROE:16.40%

ROA:3.99%

PB:2.18

PE(LYR):7.86

Loading ...

Overview Company News Filings

Oddity Tech Outlook Q2 Adjusted Ebitda USD 8-10 Million

THOMSON REUTERS

Oddity Tech Q1 Gross Margin 69.7%

THOMSON REUTERS

Oddity Tech Q1 EPS USD -0.38

THOMSON REUTERS

Oddity Tech Q1 Adjusted Ebitda USD -7 Million

THOMSON REUTERS

Oddity Tech - Expects Positive Adj Ebitda for Full Year 2026

THOMSON REUTERS

Oddity Tech Reports First Quarter 2026 Results, Makes Progress Toward Normalization

THOMSON REUTERS

U.S. Earnings Preview: Before Market Open June 2

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

Calendar of U.S. Earnings Expected in the Week Ahead

Oddity Tech Ltd expected to post earnings of 1 cent a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock

KeyBanc card data shows ‘significant improvement’ for Oddity

Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock

Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

Press Release: TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Oddity Tech schedules first-quarter results release, earnings call

ODDITY to Announce First Quarter 2026 Financial Results on June 2, 2026

Press Release: Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ODD/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ODD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","market":"US","secType":"STK","nameCN":"ODDITY Tech Ltd.","latestPrice":14.14,"timestamp":1788292800000,"preClose":14.4,"halted":0,"volume":655268,"hourTrading":{"tag":"盘后","latestPrice":14.1,"preClose":14.14,"latestTime":"16:12 EDT","volume":13751,"amount":194437.943663,"timestamp":1788293575857,"change":-0.04,"changeRate":-0.002829,"amplitude":0.002829},"delay":0,"changeRate":-0.01805555555555554,"floatShares":28586000,"shares":46124600,"eps":0.79,"marketStatus":"Post-Mkt","change":-0.26,"latestTime":"09-01 17:35:07 EDT","open":14.49,"high":15.175,"low":14.07,"amount":9491503,"amplitude":0.076736,"askPrice":15.43,"askSize":1,"bidPrice":13.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.79,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1689739200000,"exchange":"NASDAQ","adjPreClose":14.4,"preHourTrading":{"tag":"盘前","latestPrice":14.37,"preClose":14.4,"latestTime":"09:29 EDT","volume":572,"amount":8220.167384,"timestamp":1788269399999,"change":-0.03,"changeRate":-0.002083,"amplitude":0.011632},"postHourTrading":{"tag":"盘后","latestPrice":14.1,"preClose":14.14,"latestTime":"16:12 EDT","volume":13751,"amount":194437.943663,"timestamp":1788293575857,"change":-0.04,"changeRate":-0.002829,"amplitude":0.002829},"volumeRatio":0.806401,"impliedVol":1.3388,"impliedVolPercentile":0.9802},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODD\",,,,,undefined,":{"symbol":"ODD","floatShares":28586000,"roa":"3.99%","roe":"16.40%","lyrEps":1.8,"volumeRatio":0.806401,"shares":46124600,"dividePrice":0,"high":15.175,"amplitude":0.076736,"preClose":14.4,"low":14.07,"week52Low":9.2501,"pbRate":"2.18","psRate":"0.88","week52High":64.23,"institutionHeld":0,"latestPrice":14.14,"committee":0.980198,"eps":0.79,"divideRate":0,"volume":655268,"delay":0,"ttmEps":0.79,"open":14.49,"prevYearClose":40.18,"prevWeekClose":14.35,"prevMonthClose":14.4,"prevQuarterClose":15.13,"fiveDayClose":14.2,"twentyDayClose":15.31,"sixtyDayClose":9.81,"earningDate":1788883200000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODD\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"ODD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0,"defaultRemindTime":1788940800000,"name":null,"time":"Pre-MKt","dateTimestamp":1788926400000,"actualEps":null},{"market":"US","date":"2026-06-02","symbol":"ODD","fiscalQuarterEnding":"2026/03","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1780372800000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2026-02-25","symbol":"ODD","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2025-11-19","symbol":"ODD","fiscalQuarterEnding":"2025/09","expectedEps":0.24,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763528400000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2025-08-04","symbol":"ODD","fiscalQuarterEnding":"2025/06","expectedEps":0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":0.76}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.7,"sell":0.3,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7,"analysts":10,"updateTime":1780718400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODD","date":"2026-08-31","current":17.898734,"percent":0.120779,"low":6.104615,"twenty":18.932683,"median":26.737148,"eighty":37.364461,"high":144.174884,"avg":28.978641,"sd":16.660608,"marketCap":661887349},"quantilePoints":[{"date":"2023-07-21","current":130.121737,"twenty":124.979326,"median":126.90773,"eighty":128.836134,"marketCap":2827285100},{"date":"2023-07-28","current":127.857619,"twenty":126.192061,"median":128.560276,"eighty":129.606455,"marketCap":2778090339},{"date":"2023-08-04","current":144.174884,"twenty":128.138682,"median":130.121737,"eighty":138.668132,"marketCap":3132631890},{"date":"2023-08-11","current":59.921033,"twenty":128.138682,"median":131.59899,"eighty":138.150305,"marketCap":3096718967},{"date":"2023-08-18","current":49.805463,"twenty":52.028567,"median":129.262933,"eighty":135.506534,"marketCap":2573946329},{"date":"2023-08-25","current":45.155781,"twenty":48.598524,"median":91.807378,"eighty":132.13135,"marketCap":2333650744},{"date":"2023-09-01","current":45.716381,"twenty":47.266275,"median":50.709145,"eighty":131.711973,"marketCap":2362622552},{"date":"2023-09-08","current":40.286255,"twenty":46.134083,"median":49.805463,"eighty":131.410685,"marketCap":2081993665},{"date":"2023-09-15","current":40.648996,"twenty":43.649855,"median":48.206104,"eighty":130.121737,"marketCap":2100740129},{"date":"2023-09-22","current":30.701094,"twenty":40.692965,"median":47.574055,"eighty":129.262933,"marketCap":1586632553},{"date":"2023-09-29","current":31.151773,"twenty":36.878686,"median":46.562777,"eighty":127.857619,"marketCap":1609923614},{"date":"2023-10-06","current":28.491671,"twenty":32.503808,"median":45.749357,"eighty":123.693723,"marketCap":1472449544},{"date":"2023-10-13","current":31.976185,"twenty":32.503808,"median":44.402818,"eighty":59.921033,"marketCap":1652529215},{"date":"2023-10-20","current":29.832714,"twenty":31.459553,"median":41.803173,"eighty":57.306257,"marketCap":1541754654},{"date":"2023-10-27","current":29.832714,"twenty":31.15617,"median":40.714949,"eighty":54.667412,"marketCap":1541754654},{"date":"2023-11-03","current":29.678824,"twenty":30.355941,"median":40.467625,"eighty":50.479578,"marketCap":1533801609},{"date":"2023-11-10","current":30.298177,"twenty":30.305454,"median":36.878686,"eighty":50.003322,"marketCap":1598562121},{"date":"2023-11-17","current":37.221321,"twenty":30.355941,"median":36.411519,"eighty":49.783479,"marketCap":1963834134},{"date":"2023-11-24","current":37.016749,"twenty":30.445709,"median":37.119035,"eighty":49.462508,"marketCap":1953040715},{"date":"2023-12-01","current":36.693741,"twenty":30.5941,"median":37.016749,"eighty":48.26876,"marketCap":1935998475},{"date":"2023-12-08","current":40.591374,"twenty":30.734071,"median":37.17287,"eighty":48.041138,"marketCap":2141641505},{"date":"2023-12-15","current":46.060981,"twenty":30.923136,"median":37.910406,"eighty":47.753992,"marketCap":2430223438},{"date":"2023-12-22","current":50.712301,"twenty":31.153971,"median":38.59949,"eighty":48.041138,"marketCap":2675631695},{"date":"2023-12-29","current":50.884572,"twenty":31.160567,"median":38.868664,"eighty":49.761494,"marketCap":2684720890},{"date":"2024-01-05","current":46.7716,"twenty":31.28148,"median":39.765881,"eighty":49.183424,"marketCap":2467716366},{"date":"2024-01-12","current":46.965405,"twenty":31.46395,"median":40.526773,"eighty":48.323896,"marketCap":2477941710},{"date":"2024-01-19","current":45.899477,"twenty":31.472743,"median":40.645209,"eighty":48.306372,"marketCap":2421702318},{"date":"2024-01-26","current":45.684138,"twenty":31.580467,"median":40.703957,"eighty":48.306372,"marketCap":2410340824},{"date":"2024-02-02","current":45.156558,"twenty":31.989432,"median":42.12028,"eighty":48.252127,"marketCap":2382505165},{"date":"2024-02-09","current":48.246671,"twenty":32.113484,"median":43.346019,"eighty":48.217673,"marketCap":2545542596},{"date":"2024-02-16","current":46.125583,"twenty":32.418946,"median":44.467474,"eighty":48.217673,"marketCap":2433631886},{"date":"2024-02-23","current":42.389454,"twenty":32.503808,"median":43.451996,"eighty":48.101679,"marketCap":2236509975},{"date":"2024-03-01","current":45.414965,"twenty":32.586249,"median":43.346019,"eighty":47.880595,"marketCap":2396138958},{"date":"2024-03-08","current":42.187798,"twenty":32.646706,"median":43.451996,"eighty":47.880595,"marketCap":2469420590},{"date":"2024-03-15","current":43.718187,"twenty":32.976471,"median":43.684021,"eighty":47.798976,"marketCap":2559000375},{"date":"2024-03-22","current":43.038127,"twenty":33.910804,"median":43.451996,"eighty":47.751391,"marketCap":2519193702},{"date":"2024-03-28","current":41.755726,"twenty":34.121582,"median":43.229275,"eighty":47.682483,"marketCap":2444129691},{"date":"2024-04-05","current":35.33401,"twenty":34.429566,"median":43.074483,"eighty":47.592295,"marketCap":2068240969},{"date":"2024-04-12","current":35.168853,"twenty":35.003425,"median":42.938568,"eighty":47.491972,"marketCap":2058573635},{"date":"2024-04-19","current":32.672059,"twenty":33.859301,"median":42.736957,"eighty":47.44561,"marketCap":1912426280},{"date":"2024-04-26","current":30.816464,"twenty":32.666988,"median":42.389454,"eighty":47.239294,"marketCap":1803810931},{"date":"2024-05-03","current":32.701204,"twenty":32.521826,"median":42.280345,"eighty":47.139393,"marketCap":1914132280},{"date":"2024-05-10","current":30.051334,"twenty":32.188614,"median":42.12028,"eighty":47.109682,"marketCap":2161502316},{"date":"2024-05-17","current":34.470881,"twenty":32.029175,"median":41.880975,"eighty":47.036466,"marketCap":2479387030},{"date":"2024-05-24","current":28.991908,"twenty":31.962852,"median":41.668069,"eighty":46.979437,"marketCap":2085300972},{"date":"2024-05-31","current":28.39104,"twenty":31.618936,"median":40.692965,"eighty":46.967038,"marketCap":2042082299},{"date":"2024-06-07","current":35.032218,"twenty":31.466148,"median":40.618291,"eighty":46.952485,"marketCap":2519762369},{"date":"2024-06-14","current":31.434913,"twenty":31.466148,"median":40.526773,"eighty":46.846969,"marketCap":2261018998},{"date":"2024-06-21","current":31.17401,"twenty":31.40776,"median":40.286255,"eighty":46.77806,"marketCap":2242252995},{"date":"2024-06-28","current":31.039605,"twenty":31.15617,"median":39.116208,"eighty":46.676851,"marketCap":2232585660},{"date":"2024-07-05","current":32.549682,"twenty":31.153971,"median":38.825596,"eighty":46.51104,"marketCap":2341201009},{"date":"2024-07-12","current":33.300768,"twenty":31.165014,"median":38.233414,"eighty":46.411983,"marketCap":2395224351},{"date":"2024-07-19","current":31.719535,"twenty":31.193823,"median":37.851188,"eighty":46.379683,"marketCap":2281491001},{"date":"2024-07-26","current":32.889648,"twenty":31.177172,"median":37.124419,"eighty":46.315081,"marketCap":2365653680},{"date":"2024-08-02","current":30.43083,"twenty":31.177172,"median":37.016749,"eighty":46.269497,"marketCap":2188798320},{"date":"2024-08-09","current":24.621128,"twenty":31.077829,"median":36.878686,"eighty":46.15167,"marketCap":2152403648},{"date":"2024-08-16","current":25.909103,"twenty":30.914687,"median":36.319047,"eighty":46.132383,"marketCap":2264999665},{"date":"2024-08-23","current":24.744722,"twenty":30.826367,"median":35.664326,"eighty":46.112663,"marketCap":2163208317},{"date":"2024-08-30","current":23.938111,"twenty":30.576415,"median":35.479654,"eighty":46.043754,"marketCap":2092693640},{"date":"2024-09-06","current":21.999645,"twenty":30.415298,"median":35.251431,"eighty":45.974846,"marketCap":1923230948},{"date":"2024-09-13","current":22.858294,"twenty":30.138302,"median":35.032218,"eighty":45.974846,"marketCap":1998294959},{"date":"2024-09-20","current":23.144511,"twenty":29.832714,"median":34.577614,"eighty":45.899477,"marketCap":2023316296},{"date":"2024-09-27","current":25.837549,"twenty":29.733784,"median":34.493388,"eighty":45.749357,"marketCap":2258744331},{"date":"2024-10-04","current":26.907033,"twenty":29.206161,"median":34.203986,"eighty":45.716381,"marketCap":2352239691},{"date":"2024-10-11","current":26.632604,"twenty":28.857503,"median":34.05976,"eighty":45.700078,"marketCap":2328248903},{"date":"2024-10-18","current":26.737148,"twenty":28.675661,"median":33.782046,"eighty":45.684138,"marketCap":2337388251},{"date":"2024-10-25","current":24.829219,"twenty":28.39104,"median":33.498422,"eighty":45.587236,"marketCap":2170595150},{"date":"2024-11-01","current":24.874957,"twenty":27.774359,"median":33.138619,"eighty":45.414965,"marketCap":2174593614},{"date":"2024-11-08","current":25.903059,"twenty":26.907033,"median":32.701204,"eighty":45.328829,"marketCap":2624135294},{"date":"2024-11-15","current":22.412856,"twenty":26.554196,"median":32.64481,"eighty":45.156558,"marketCap":2270556768},{"date":"2024-11-22","current":25.688798,"twenty":26.266873,"median":32.549682,"eighty":45.155781,"marketCap":2602429343},{"date":"2024-11-29","current":26.196259,"twenty":26.231703,"median":32.526331,"eighty":45.078881,"marketCap":2653838175},{"date":"2024-12-06","current":27.019473,"twenty":26.102043,"median":32.510933,"eighty":44.930453,"marketCap":2737234726},{"date":"2024-12-13","current":27.882156,"twenty":26.129486,"median":32.397731,"eighty":44.829243,"marketCap":2824629741},{"date":"2024-12-20","current":24.673876,"twenty":26.102043,"median":32.284642,"eighty":44.80743,"marketCap":2499611678},{"date":"2024-12-27","current":24.555468,"twenty":26.074468,"median":32.122117,"eighty":44.68052,"marketCap":2487616283},{"date":"2025-01-03","current":24.036731,"twenty":26.028044,"median":31.982415,"eighty":44.572573,"marketCap":2435065032},{"date":"2025-01-10","current":24.916329,"twenty":25.91918,"median":31.969518,"eighty":44.533395,"marketCap":2524173675},{"date":"2025-01-17","current":25.299744,"twenty":25.850651,"median":31.948814,"eighty":44.510542,"marketCap":2563015904},{"date":"2025-01-24","current":24.983991,"twenty":25.688798,"median":31.719535,"eighty":44.467474,"marketCap":2531028186},{"date":"2025-01-31","current":26.906704,"twenty":25.660605,"median":31.631647,"eighty":44.252135,"marketCap":2725810541},{"date":"2025-02-07","current":24.025454,"twenty":25.660605,"median":31.600943,"eighty":44.067933,"marketCap":2433922614},{"date":"2025-02-14","current":24.245353,"twenty":25.528357,"median":31.476041,"eighty":43.718187,"marketCap":2456199775},{"date":"2025-02-21","current":24.809199,"twenty":25.393274,"median":31.447233,"eighty":43.663521,"marketCap":2513320700},{"date":"2025-02-28","current":26.194867,"twenty":25.287339,"median":31.363758,"eighty":43.611255,"marketCap":2658543217},{"date":"2025-03-07","current":24.561126,"twenty":25.149762,"median":31.267028,"eighty":43.481918,"marketCap":2492733193},{"date":"2025-03-14","current":25.259729,"twenty":25.127573,"median":31.17401,"eighty":43.282433,"marketCap":2563635122},{"date":"2025-03-21","current":23.829518,"twenty":25.089994,"median":31.105558,"eighty":43.231428,"marketCap":2418481566},{"date":"2025-03-28","current":23.620487,"twenty":25.062794,"median":30.968449,"eighty":43.177394,"marketCap":2397266815},{"date":"2025-04-04","current":20.886583,"twenty":24.97973,"median":30.909153,"eighty":43.121556,"marketCap":2119800209},{"date":"2025-04-11","current":22.872376,"twenty":24.935811,"median":30.865977,"eighty":43.052669,"marketCap":2321340339},{"date":"2025-04-17","current":23.075906,"twenty":24.876099,"median":30.80242,"eighty":42.991494,"marketCap":2341996807},{"date":"2025-04-25","current":24.341093,"twenty":24.812177,"median":30.590011,"eighty":42.947303,"marketCap":2470401876},{"date":"2025-05-02","current":33.211688,"twenty":24.800183,"median":30.612672,"eighty":42.912727,"marketCap":3531697688},{"date":"2025-05-09","current":37.275211,"twenty":24.812177,"median":30.809442,"eighty":42.852836,"marketCap":3963808661},{"date":"2025-05-16","current":33.075187,"twenty":24.823197,"median":30.881482,"eighty":42.719469,"marketCap":3517182333},{"date":"2025-05-23","current":36.009954,"twenty":24.840888,"median":30.917059,"eighty":42.57047,"marketCap":3829262479},{"date":"2025-05-30","current":37.968215,"twenty":24.859184,"median":31.004027,"eighty":42.466444,"marketCap":4037502005},{"date":"2025-06-06","current":40.472479,"twenty":24.875718,"median":31.151773,"eighty":42.376534,"marketCap":4303802953},{"date":"2025-06-13","current":38.84497,"twenty":24.888137,"median":31.181916,"eighty":42.353632,"marketCap":4130735251},{"date":"2025-06-20","current":36.618957,"twenty":24.907308,"median":31.267028,"eighty":42.321149,"marketCap":3894023297},{"date":"2025-06-27","current":37.637463,"twenty":24.9212,"median":31.363758,"eighty":42.207431,"marketCap":4002330181},{"date":"2025-07-03","current":39.798375,"twenty":24.940682,"median":31.434913,"eighty":42.187798,"marketCap":4232119427},{"date":"2025-07-11","current":38.424967,"twenty":24.946182,"median":31.476041,"eighty":42.12028,"marketCap":4086072618},{"date":"2025-07-18","current":37.17546,"twenty":24.957184,"median":31.58513,"eighty":42.056896,"marketCap":3953201285},{"date":"2025-07-25","current":36.450956,"twenty":24.962685,"median":31.617964,"eighty":41.958776,"marketCap":3876158244},{"date":"2025-08-01","current":36.786958,"twenty":24.983991,"median":31.719535,"eighty":41.803173,"marketCap":3911888350},{"date":"2025-08-08","current":29.269388,"twenty":24.988656,"median":31.680004,"eighty":41.755726,"marketCap":3223525522},{"date":"2025-08-15","current":29.576073,"twenty":25.039696,"median":31.613107,"eighty":41.668069,"marketCap":3257301638},{"date":"2025-08-22","current":30.491058,"twenty":25.068568,"median":31.584654,"eighty":40.714949,"marketCap":3358071703},{"date":"2025-08-29","current":30.947283,"twenty":25.079845,"median":31.470545,"eighty":40.692965,"marketCap":3408317165},{"date":"2025-09-05","current":31.494754,"twenty":25.083205,"median":31.459553,"eighty":40.65779,"marketCap":3468611719},{"date":"2025-09-12","current":31.935772,"twenty":25.085195,"median":31.488146,"eighty":40.645966,"marketCap":3517182333},{"date":"2025-09-19","current":31.793835,"twenty":25.089994,"median":31.584179,"eighty":40.616226,"marketCap":3501550411},{"date":"2025-09-26","current":29.994279,"twenty":25.105422,"median":31.49222,"eighty":40.594895,"marketCap":3303359978},{"date":"2025-10-03","current":30.739447,"twenty":25.114201,"median":31.481537,"eighty":40.590201,"marketCap":3385427566},{"date":"2025-10-10","current":26.927161,"twenty":25.127573,"median":31.451808,"eighty":40.571566,"marketCap":2965569012},{"date":"2025-10-17","current":26.01968,"twenty":25.135101,"median":31.389658,"eighty":40.56278,"marketCap":2865625373},{"date":"2025-10-24","current":24.575011,"twenty":25.135101,"median":31.29655,"eighty":40.533764,"marketCap":2706519695},{"date":"2025-10-31","current":22.697464,"twenty":25.089994,"median":31.260978,"eighty":40.483338,"marketCap":2499739752},{"date":"2025-11-07","current":20.840778,"twenty":25.062794,"median":31.168388,"eighty":40.3235,"marketCap":2295257365},{"date":"2025-11-14","current":21.127625,"twenty":24.961585,"median":31.125566,"eighty":40.286255,"marketCap":2326848745},{"date":"2025-11-21","current":20.632506,"twenty":24.914074,"median":31.026394,"eighty":40.195833,"marketCap":2272856204},{"date":"2025-11-28","current":22.556538,"twenty":24.864441,"median":30.973992,"eighty":40.067661,"marketCap":2484805645},{"date":"2025-12-05","current":23.453377,"twenty":24.800183,"median":30.947283,"eighty":39.942199,"marketCap":2583600507},{"date":"2025-12-12","current":23.171811,"twenty":24.744189,"median":30.91898,"eighty":39.889726,"marketCap":2552583516},{"date":"2025-12-19","current":22.108118,"twenty":24.698354,"median":30.913106,"eighty":39.830715,"marketCap":2435408215},{"date":"2025-12-26","current":21.97255,"twenty":24.603474,"median":30.881482,"eighty":39.790815,"marketCap":2420474108},{"date":"2026-01-02","current":20.950571,"twenty":24.5566,"median":30.865977,"eighty":39.747975,"marketCap":2307893917},{"date":"2026-01-09","current":20.079803,"twenty":24.511489,"median":30.793745,"eighty":39.569474,"marketCap":2211970999},{"date":"2026-01-16","current":18.426908,"twenty":24.453976,"median":30.739447,"eighty":39.33668,"marketCap":2029889771},{"date":"2026-01-23","current":18.270483,"twenty":24.345533,"median":30.673548,"eighty":39.245507,"marketCap":2012658109},{"date":"2026-01-30","current":17.535284,"twenty":24.313015,"median":30.590011,"eighty":39.075971,"marketCap":1931669298},{"date":"2026-02-06","current":15.001193,"twenty":24.204717,"median":30.513869,"eighty":38.986908,"marketCap":1652516376},{"date":"2026-02-13","current":14.396348,"twenty":24.048695,"median":30.485989,"eighty":38.976221,"marketCap":1585887283},{"date":"2026-02-20","current":15.950173,"twenty":23.978855,"median":30.423064,"eighty":38.890175,"marketCap":1757055125},{"date":"2026-02-27","current":7.139339,"twenty":23.850132,"median":30.333914,"eighty":38.866509,"marketCap":790646086},{"date":"2026-03-06","current":7.224918,"twenty":23.762072,"median":30.274296,"eighty":38.85757,"marketCap":800123500},{"date":"2026-03-13","current":6.950028,"twenty":23.706908,"median":30.138302,"eighty":38.84707,"marketCap":769680898},{"date":"2026-03-20","current":7.187922,"twenty":23.614586,"median":30.055287,"eighty":38.79877,"marketCap":796026424},{"date":"2026-03-27","current":6.865617,"twenty":23.526973,"median":29.994279,"eighty":38.783466,"marketCap":760332712},{"date":"2026-04-02","current":6.855385,"twenty":23.427349,"median":29.832714,"eighty":38.753843,"marketCap":759199579},{"date":"2026-04-10","current":7.072813,"twenty":23.171299,"median":29.799737,"eighty":38.548868,"marketCap":783278670},{"date":"2026-04-17","current":7.668822,"twenty":23.13114,"median":29.705337,"eighty":38.419858,"marketCap":849283708},{"date":"2026-04-24","current":7.92462,"twenty":22.959771,"median":29.615359,"eighty":38.380611,"marketCap":877612050},{"date":"2026-05-01","current":7.326053,"twenty":22.880081,"median":29.470231,"eighty":38.282735,"marketCap":811323729},{"date":"2026-05-08","current":7.617663,"twenty":22.847068,"median":29.327683,"eighty":38.184209,"marketCap":843618039},{"date":"2026-05-15","current":6.415412,"twenty":22.722307,"median":29.206161,"eighty":38.041491,"marketCap":710474829},{"date":"2026-05-22","current":6.338673,"twenty":22.581017,"median":28.928656,"eighty":37.95404,"marketCap":701976327},{"date":"2026-05-29","current":6.701906,"twenty":22.463575,"median":28.85355,"eighty":37.93304,"marketCap":742202573},{"date":"2026-06-05","current":11.066918,"twenty":22.355552,"median":28.723098,"eighty":37.913591,"marketCap":570532817},{"date":"2026-06-12","current":12.045027,"twenty":22.082048,"median":28.568928,"eighty":37.870529,"marketCap":620957267},{"date":"2026-06-18","current":12.056017,"twenty":22.028863,"median":28.441356,"eighty":37.806965,"marketCap":621523834},{"date":"2026-06-26","current":14.440844,"twenty":21.88078,"median":28.164079,"eighty":37.786268,"marketCap":744468840},{"date":"2026-07-02","current":18.69397,"twenty":21.779625,"median":28.062977,"eighty":37.763464,"marketCap":963730211},{"date":"2026-07-10","current":19.045649,"twenty":21.529345,"median":27.910348,"eighty":37.653213,"marketCap":981860351},{"date":"2026-07-17","current":14.619425,"twenty":21.127625,"median":27.658443,"eighty":37.642713,"marketCap":753675212},{"date":"2026-07-24","current":13.894717,"twenty":20.840778,"median":27.290118,"eighty":37.637463,"marketCap":716314323},{"date":"2026-07-31","current":13.102906,"twenty":20.627222,"median":27.097913,"eighty":37.608063,"marketCap":675494093},{"date":"2026-08-07","current":12.096366,"twenty":20.299418,"median":26.927161,"eighty":37.545851,"marketCap":623603970},{"date":"2026-08-14","current":11.926373,"twenty":19.78552,"median":26.9103,"eighty":37.435797,"marketCap":614840304},{"date":"2026-08-21","current":11.192718,"twenty":19.351603,"median":26.903692,"eighty":37.382312,"marketCap":577018170},{"date":"2026-08-28","current":13.411578,"twenty":19.023056,"median":26.740169,"eighty":37.366561,"marketCap":691407064},{"date":"2026-08-31","current":12.838969,"twenty":18.932683,"median":26.737148,"eighty":37.364461,"marketCap":661887349}],"updateTime":1788298507936},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ODD\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640912032","title":"Oddity Tech Outlook Q2 Adjusted Ebitda USD 8-10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2640912032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640912032?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nPLXMVR4KV:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640791222","title":"Oddity Tech Q1 Gross Margin 69.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640791222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640791222?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nPLXMVR4KV:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640201912","title":"Oddity Tech Q1 EPS USD -0.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2640201912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640201912?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nPLXMVR4KV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","ODD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640122799","title":"Oddity Tech Q1 Adjusted Ebitda USD -7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2640122799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640122799?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nPLXMVR4KV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640122219","title":"Oddity Tech - Expects Positive Adj Ebitda for Full Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640122219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640122219?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nPLXMVR4KV:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640912788","title":"Oddity Tech Reports First Quarter 2026 Results, Makes Progress Toward Normalization","url":"https://stock-news.laohu8.com/highlight/detail?id=2640912788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640912788?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUA2WYXTS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","IE0009354923.USD","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640919153","title":"U.S. Earnings Preview: Before Market Open June 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2640919153","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640919153?lang=en_us&edition=fundamental","pubTime":"2026-06-02 17:31","pubTimestamp":1780392660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results before the market opens.Ecolab Inc.'s second-quarter EPS is forecast at $2.00, compared with $1.84 in the prior-year period. Adjusted EPS is forecast at $2.07.Dollar General Corp.'s first-quarter EPS is forecast at $1.88, compared with $1.78 in the prior-year period. Adjusted EPS is forecast at $1.89.Donaldson Co. Inc.'s third-quarter EPS is forecast at $1.04, compared with 48 cents in the prior-year period. Adjusted EPS is forecast at $1.05.Victoria's Secret & Co.'s first-quarter EPS is forecast at 31 cents, compared with a loss of 2 cents in the prior-year period. Adjusted EPS is forecast at 32 cents.ODDITY Tech Ltd.'s first-quarter EPS is forecast at a loss of 16 cents. Adjusted EPS is forecast at a loss of 3 cents.Citi Trends Inc.'s first-quarter EPS is forecast at 54 cents, compared with 11 cents in","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4161","BK4597","LU2229751404.USD","LU2473716301.USD","LU1923622614.USD","LU1923622291.USD","LU2272731865.HKD","LU1165135440.EUR","LU2322448791.USD","LU1892829315.USD","BK4155","LU0070302665.USD","LU1623119135.USD","LU2041044095.USD","LU1721429402.USD","LU1585245621.USD","LU0323239441.USD","LU0823417653.USD","LU1721429741.USD","BK4183","ECL","CTRN","LU1620156130.USD","LU1430594728.SGD","LU2125909593.SGD","BK4588","LU2272731782.SGD","LU0208291251.USD","LU1992135399.USD","IE0009354923.USD","LU2125909247.SGD","LU1620156213.USD","BK4504","LU2433249047.HKD","LU2506952170.USD","LU1989763690.USD","AVXL","DCI","LU2506951958.HKD","LU0072461881.USD","DG","LU1923621640.USD","LU2125910336.SGD","GB00BDT5M118.USD","BK4094","LU0323240290.USD","ODD","LU1989763427.SGD","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959336","title":"Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959336","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959336?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:30","pubTimestamp":1780313400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., June  01, 2026  (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304241/0/en/Intellia-Therapeutics-to-Report-Additional-Phase-3-HAELO-Data-for-Lonvoguran-Ziclumeran-lonvo-z-in-Late-Breaking-Oral-Presentation-at-EAACI-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4556","NTLA","IE00BLDYK493.USD","BK4183","BK4535","BK4198","LU0106261612.USD","LU0012050646.USD","LU1861558580.USD","ODD","IE00B19Z6F94.USD","BK4588","IE0034390439.USD","HAE","LU0205194284.USD","CRSP","LU1169589451.USD","LU1861559042.SGD","BK4585","LU1169590202.USD","IE00B64QTZ34.USD","BK4139","LU0205193047.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930042","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640930042?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:00","pubTimestamp":1780308000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Dollar Gen Corp                                   1Q      1.89   6:50 AM. ·Five Below Inc                                  1Q      1.76   4:01 PM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOCU","PANW","WOOF","ABM","BF.B","PICS","CGNT","HPE","SAIC","HIVE","RBRK","DG","TTC","TTAN","CRDO","CIEN","ODD","VEEV","SIG","AGX","CHPT","AVGO","MDT","FIVE","OESX","CAL","CRWD","SPWH","WLTH","DCI","NTSK","GWRE","LULU","GTLB","VSCO","CURV","CMCO","ULTA","OLLI","IOT","VBNK","PVH","NX","BF.A","VSXY","DSGX","CXM","PL","COO","GIII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639424627","title":"Oddity Tech Ltd  expected to post earnings of 1 cent a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2639424627","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639424627?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:35","pubTimestamp":1780058108,"startTime":"0","endTime":"0","summary":"Oddity Tech Ltd  expected to post earnings of 1cent a share - Earnings Preview Oddity Tech Ltd ODD.OQ ODD.O is expected to  show a fall in quarterly revenue when it reports  results on June 2 for the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL8N42611B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638466108","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2638466108","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638466108?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:00","pubTimestamp":1779962400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOO","FUFU","CHPT","OKTA","DSGX","COST","AMBA","KNOP","FUTU","PICS","DLTR","GAP","CM","ESTC","MRDN","GTLB","PATH","GCO","HRL","ASAN","CXM","NTAP","NTSK","KSS","FIVE","HQY","ATS","LE","PLAB","PD","DELL","LI","CRDO","AVGO","ODD","PANW","CGNT","ATHM","ADSK","CRWD","DG","BURL","BBW","DCI","MDT","AEO","HPE","MDB","OLLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342955","title":"Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342955","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637342955?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:15","pubTimestamp":1779484500,"startTime":"0","endTime":"0","summary":"– Financing includes leading U.S. biotechnology institutional investors and mutual funds – LOS ANGELES, CA, May  22, 2026  (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300383/0/en/Immix-Biopharma-Announces-Closing-of-150-Million-Underwritten-Offering-of-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","LU2357305700.SGD","LU1791710582.SGD","LU0320765646.SGD","ODD","LU2264538146.SGD","LU1244550494.USD","LU0225283273.USD","IE00BKVL7J92.USD","LU0053666078.USD","BK4516","LU0528227936.USD","LU1989772923.USD","LU1732800096.USD","LU0912757837.SGD","LU0098860793.USD","LU1720051017.SGD","LU1244550577.SGD","BK4183","LU0106261372.USD","LU0882574139.USD","LU1988902786.USD","LU2347655156.SGD","BK4585","LU0557290698.USD","LU1668664300.SGD","LU0267386448.USD","LU0971096721.USD","LU2487616109.SGD","BK4534","LU0390134368.USD","LU2023251221.USD","LU1791710400.SGD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU1720051108.HKD","LU2271345857.HKD","IE0009354923.USD","LU0106831901.USD","LU0234570918.USD","LU2089284900.SGD","LU1732799900.SGD","BK4504","LU0314104364.USD","LU0158827948.USD","LU1162221912.USD","LU0795875086.SGD","LU1244550221.USD","LU2111349929.HKD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637353557","title":"KeyBanc card data shows ‘significant improvement’ for Oddity","url":"https://stock-news.laohu8.com/highlight/detail?id=2637353557","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637353557?lang=en_us&edition=fundamental","pubTime":"2026-05-22 00:30","pubTimestamp":1779381013,"startTime":"0","endTime":"0","summary":"KeyBanc says the firm’s credit card data shows “significant improvement” for Oddity (ODD) in May following weakness seen in April. Consolidated spe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keybanc-card-data-shows-significant-improvement-for-oddity-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keybanc-card-data-shows-significant-improvement-for-oddity-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382217","title":"Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382217","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382217?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:30","pubTimestamp":1779359400,"startTime":"0","endTime":"0","summary":"LOS ANGELES, May  21, 2026  (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a global leader in AL Amyloidosis, today announced the pricing of an underwritten","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299136/0/en/Immix-Biopharma-Announces-Pricing-of-150-Million-Underwritten-Offering-of-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU1732799900.SGD","LU0528227936.USD","LU0912757837.SGD","LU0006306889.USD","LU1989772923.USD","LU1074936037.SGD","LU2347655156.SGD","LU0098860793.USD","LU0158827781.USD","IE0009354923.USD","LU0882574139.USD","LU1988902786.USD","LU2028103732.USD","LU2111349929.HKD","BK4534","BK4581","BK4183","LU0053666078.USD","LU1244550221.USD","LU2271345857.HKD","LU0314104364.USD","BK4516","BK4585","LU1720051108.HKD","LU0320765646.SGD","LU0557290698.USD","LU0795875169.SGD","LU2089284900.SGD","IE00BKVL7J92.USD","LU1791710582.SGD","LU0795875086.SGD","LU2089283258.USD","BK4588","IE00BZ1G4Q59.USD","LU2487616109.SGD","LU1720051017.SGD","LU1244550577.SGD","LU1791710400.SGD","LU0225283273.USD","LU0234570918.USD","LU0106261372.USD","LU0390134368.USD","LU1668664300.SGD","LU0106831901.USD","ODD","LU1363072403.SGD","LU1732800096.USD","BK4127","LU1244550494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637843043","title":"Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2637843043","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637843043?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:00","pubTimestamp":1779357600,"startTime":"0","endTime":"0","summary":"– Of first 20 patients, all four MRD-negative patients have converted to complete response (CR) – – CR rate now 95% (19 of 20 patients) – – All CRs reached within 1 year of follow-up post-dosing – – N","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299108/0/en/Immix-Biopharma-Announces-95-Complete-Response-Rate-in-Interim-Update-From-relapsed-refractory-AL-Amyloidosis-Clinical-Trial-NEXICART-2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","LU1169589451.USD","CAR","BK4161","IE0009354923.USD","ODD","BK4183","BK4022","IE0034390439.USD","LU1169590202.USD","IE00B19Z6F94.USD","BK4572","BK4230","CR","AL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636260510","title":"Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2636260510","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636260510?lang=en_us&edition=fundamental","pubTime":"2026-05-18 17:10","pubTimestamp":1779095400,"startTime":"0","endTime":"0","summary":"Current treatments are limited by suboptimal disease control and treatment-related complications3,4. Asedebart  is a novel, investigational anti-ACTH monoclonal antibody targeting underlying disease pathology. Proof-of-concept trials are currently ongoing to evaluate efficacy and safety of asedebart in CD and CAH. VALBY, Denmark, May 18, 2026 /PRNewswire/ --Lundbeck today announced that orphan drug designation  has been granted in Japan by the Ministry of Health, Labour and Welfare  for asedebart  for the treatment of patients with congenital adrenal hyperplasia  and Cushing's disease .Asedebart, a novel monoclonal antibody targeting ACTH is advancing in clinical development as a potential first-in-class treatment for conditions characterized by excess ACTH. By targeting an underlying disease mechanism, asedebart aims to offer a new treatment approach to managing CAH. Asedebart, formerly designated Lu AG13909, has recently been assigned an International Nonproprietary Name  and has rec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/lundbeck-receives-orphan-drug-designation-in-japan-for-asedebart-for-the-treatment-of-patients-with-congenital-adrenal-hyperplasia-and-cushings-disease-302774519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","LU0052756011.USD","LU0006061336.USD","LU1880398554.USD","BK4183","BK4116","CAH","LU0211327993.USD","BK4585","SG9999001440.SGD","LU0792757196.USD","LU0211328371.USD","LU0072461881.USD","INN","LU0889566641.SGD","ODD","LU1983299246.USD","LU0162691827.USD","LU1267930227.SGD","LU0154236417.USD","BK4175","BK4181","BK4218","CD","LU0310800965.SGD","LU1267930813.SGD","LU1880398471.USD","LU1267930490.SGD","BK4023","LU1571399168.USD","BK4588","LU0310799852.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635058439","title":"Press Release: TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058439?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:00","pubTimestamp":1778878800,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., May 15, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc.  , a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company's first quarter ended March 31, 2026, and provided a corporate update.\"I am very pleased with the progress we have made this past quarter as we continue to execute upon our corporate and development strategy. Importantly, we recently established a $50 million non-equity-based source of operating capital in the form of credit facility with our largest stockholder on attractive terms for the company allowing us to fund operations beyond anticipated top-line data in our lead IFx-2.0 program,\" said Dr. James Bianco, President and CEO of TuHURA Biosciences. \"With the financing optionality provided by the credit facility, we now look forward to several anticipated key upcoming milestones, including: meeting with the FDA to discuss our IND and development plan for o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4139","ODD","R","IE0009354923.USD","BK4183","HURA","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635308732","title":"Oddity Tech schedules first-quarter results release, earnings call","url":"https://stock-news.laohu8.com/highlight/detail?id=2635308732","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635308732?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:02","pubTimestamp":1778850159,"startTime":"0","endTime":"0","summary":"Oddity Tech schedules release of first-quarter 2026 financial results before U.S. market open on June 2, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL4X82dQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","ODD","LU0314104364.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4585","BK4588","BK4183","IE00B3QW5Z07.USD","SG9999014039.USD","SG9999014013.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635208722","title":"ODDITY to Announce First Quarter 2026 Financial Results on June 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635208722","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635208722?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:00","pubTimestamp":1778850000,"startTime":"0","endTime":"0","summary":"NEW YORK, May  15, 2026  (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its first quarter 2026 financial results before the market open on Tuesday,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295899/0/en/ODDITY-to-Announce-First-Quarter-2026-Financial-Results-on-June-2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODD","IE0009354923.USD","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635710850","title":"Press Release: Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2635710850","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635710850?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:45","pubTimestamp":1778762700,"startTime":"0","endTime":"0","summary":"Secured strategic financing vehicle for up to $40 million. Continued operational streamlining contributed to substantially reduced quarterly net loss and cash burn. SOUTH SAN FRANCISCO, Calif., May 14, 2026  -- Senti Biosciences Holdings, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the first quarter ended March 31, 2026, and provided recent business highlights.In addition, Senti announced that it identified a specific Donor X attribute that correlates with efficacy of SENTI-202, with 50%  of the patients achieving a composite CR  when they received any SENTI-202 doses manufactured from Donor X-characteristic derived NK cells in Cycle 1. The Donor X attribute is found in 50% of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","BK4539","BK4585","LU2237443895.HKD","BK4588","LU0149725797.USD","IE00BKVL7J92.USD","LU2237443978.SGD","LU2237443382.USD","LU0267386448.USD","BK4139","SNTI","IE00BZ1G4Q59.USD","LU2237443465.HKD","LU0971096721.USD","LABU","LU0170899867.USD","IE00BFXG1179.USD","LU0882574139.USD","CMC","BK4183","LU2746668974.SGD","IE00B1BXHZ80.USD","IE00BHPRN162.USD","BK4006","LU2237443549.SGD","LU2237443622.USD","IE0009354923.USD","ODD","LU2746668461.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":129,"code":"91000000","status":"200"}]}}